Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma

Sagara Hospital, Japan

Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery

Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers

Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd

Palmer Eye Institute, Bascombe